How were Janus Capital Group's earnings last quarter?

Janus Capital Group Inc (NYSE:JNS) announced its quarterly earnings data on Tuesday, July, 26th. The asset manager reported $0.21 EPS for the quarter, missing the consensus estimate of $0.22 by $0.01. The asset manager had revenue of $251.90 million for the quarter, compared to analysts' expectations of $258.50 million. The firm's revenue for the quarter was down 7.4% on a year-over-year basis. During the same period last year, the business earned $0.24 EPS.

Is Janus Capital Group a good dividend stock?

Janus Capital Group (NYSE:JNS) pays an annual dividend of $0.44 per share and currently has a dividend yield of 0.00%. The dividend payout ratio is 25.88%. This payout ratio is at a healthy, sustainable level, below 75%. Read our dividend analysis for JNS .

What other stocks do shareholders of Janus Capital Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Janus Capital Group investors own include Janus Henderson Group (JHG) , BlackRock (BLK) , Intel (INTC) , Rite Aid (RAD) , Banco Santander (SAN) , Covenant Transportation Group (CVTI) , Huntington Bancshares (HBAN) , RWE Aktiengesellschaft (RWEOY) , Alcoa (AA) and Allena Pharmaceuticals (ALNA) .

NYSE:JNS

Janus Capital Group (JNS) Stock Price, News & Analysis

→ Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad)

Free JNS Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Today's Range: $14.17
▼
$14.17
50-Day Range: N/A
52-Week Range: $11.95
▼
$16.62

Volume: N/A
Average Volume: 2.45 million shs
Market Capitalization: N/A

P/E Ratio: 8.34
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Janus Capital Group alerts:

Ad Behind the Markets

Tiny Biotech Stock Wins $75 Billion Patent

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

Find out more here >>>

About Janus Capital Group Stock (NYSE:JNS)

Janus Capital Group Inc. provides investment management, administration, distribution and related services to financial advisors, individuals and institutional clients through mutual funds, separate accounts, other pooled investment vehicles, exchange-traded products (ETPs) and subadvised relationships (collectively referred to as investment products) in both domestic and international markets. The Company operates through investment management business segment. The Company provides investment management solutions across a range of disciplines, including fundamental the United States and global equities (growth and value), mathematical equities, fixed income and alternatives. As of December 31, 2016, the Company's investment products were distributed through three primary channels: intermediary, institutional and self-directed. Each distribution channel focuses on specific investor groups and the requirements of each group.

Ad Behind the Markets

Tiny Biotech Stock Wins $75 Billion Patent

Find out more here >>>

JNS Stock News Headlines

February 27, 2024 | benzinga.com

Earnings Outlook For Janus Intl Gr

February 16, 2024 | seekingalpha.com

Janus International: A Great, Long-Term Story, But Fairly-Priced Now

April 19, 2024 | Altimetry (Ad)

Secret Bull Market Starts in This Unusual Sector

"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.

February 2, 2024 | markets.businessinsider.com

What Analysts Are Saying About Janus Henderson Group Stock

January 25, 2024 | seekingalpha.com

Janus International: Top Building Products Stock (SA Quant)

January 17, 2024 | seekingalpha.com

Bill Gross

January 5, 2024 | msn.com

The Disney-Nelson Peltz Proxy Battle, Explained

December 13, 2023 | msn.com

Traders lift bets on UK interest rate cuts in 2024 after economy shrinks in October – business live

April 19, 2024 | Altimetry (Ad)

Secret Bull Market Starts in This Unusual Sector

November 30, 2023 | seekingalpha.com

Janus International: Undervalued With Strong Future Growth Prospects

November 5, 2023 | wsj.com

Janus Henderson Balanced Fund;I

November 2, 2023 | msn.com

Janus Henderson: Downside Concerns Eased, Buy Rating Reinstated

October 14, 2023 | thestreet.com

Here's Bill Gross' First Investment Outlook at Janus Capital

September 3, 2023 | msn.com

Janus Capital Management LLC - Janus Henderson Mortgage-Backed Securities ETF (JMBS) Declares $0.18 Dividend

August 29, 2023 | news.yahoo.com

Watch: Dr. Janus Adams on her time at the March on Washington

July 19, 2023 | investing.com

Janus Henderson Capital Funds Plc - Global Life Sciences Fund Class I2 Usd (0P00000ITE)

July 13, 2023 | thestreet.com

Janus Capital Group Inc. (JNS): Today's Featured Financial Services Loser

July 6, 2023 | msn.com

JP Morgan Maintains Janus Henderson Group (JHG) Underweight Recommendation

June 29, 2023 | msn.com

Janus International: Good Growth Prospects And Reasonable Valuation Make It A Buy

June 16, 2023 | msn.com

Ex-Janus Henderson analyst denies insider dealing, money laundering

June 9, 2023 | technews.tmcnet.com

J&J Green Paper Inc. Secures Global Agreements to Revolutionize Paper Industry with JANUS®, a Breakthrough Eco-Friendly Solution

May 15, 2023 | msn.com

US-based investor Janus Henderson marks down PharmEasy's valuation by half to $2.8 bn

March 19, 2023 | thestreet.com

Mutual Funds Touched by Insider Trading Probe

February 11, 2023 | morningstar.com

Janus Henderson Abs Ret Inc Opports T

January 25, 2023 | bloomberg.com

UK Charges Ex-Janus Analyst With Insider Dealing, Laundering

January 24, 2023 | morningstar.com

Janus Henderson Global Life Sciences D

January 21, 2023 | seekingalpha.com

JBI Janus International Group, Inc.

See More Headlines

Receive JNS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Janus Capital Group and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 7/26/2016
Today: 4/19/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Sector: N/A
Industry: N/A
Sub-Industry: Asset Management & Custody Banks
Current Symbol: NYSE:JNS
CUSIP: 47102X10
CIK: 1065865
Web: www.janus.com
Phone: +1-303-3333863
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: 8.34
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

Glenn S. Schafer CPA
Independent Chairman of the Board
Bruce L. Koepfgen
President
Richard M. Weil
Chief Executive Officer, Director
Jennifer J. McPeek
Chief Financial Officer, Executive Vice President
Enrique Chang
President - Head of Investments
Augustus Wing Chun Cheh
President - Janus International
Jeffrey J. Diermeier
Independent Director
Eugene Flood Jr.
Independent Director
J. Richard Fredericks
Independent Director
Deborah R. Gatzek
Independent Director

JNS Stock Analysis - Frequently Asked Questions

How were Janus Capital Group's earnings last quarter?: Janus Capital Group Inc (NYSE:JNS) announced its quarterly earnings data on Tuesday, July, 26th. The asset manager reported $0.21 EPS for the quarter, missing the consensus estimate of $0.22 by $0.01. The asset manager had revenue of $251.90 million for the quarter, compared to analysts' expectations of $258.50 million. The firm's revenue for the quarter was down 7.4% on a year-over-year basis. During the same period last year, the business earned $0.24 EPS.
Is Janus Capital Group a good dividend stock?: Janus Capital Group (NYSE:JNS) pays an annual dividend of $0.44 per share and currently has a dividend yield of 0.00%. The dividend payout ratio is 25.88%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for JNS.
What other stocks do shareholders of Janus Capital Group own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Janus Capital Group investors own include Janus Henderson Group (JHG), BlackRock (BLK), Intel (INTC), Rite Aid (RAD), Banco Santander (SAN), Covenant Transportation Group (CVTI), Huntington Bancshares (HBAN), RWE Aktiengesellschaft (RWEOY), Alcoa (AA) and Allena Pharmaceuticals (ALNA).

This page (NYSE:JNS) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Janus Capital Group (JNS) Stock Price, News & Analysis

About Janus Capital Group Stock (NYSE:JNS)

JNS Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

JNS Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info